NATCO Pharma Limited (BOM:524816)
India · Delayed Price · Currency is INR 1,016.75
-158.85 (-13.51%)
At close: May 29, 2026
NATCO Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 14,185 | 18,854 | 13,883 | 7,153 | 1,700 |
Depreciation & Amortization | 2,066 | 1,812 | 1,822 | 1,592 | 1,394 |
Other Amortization | - | 40 | 46 | 46 | 32 |
Loss (Gain) From Sale of Assets | 251 | -901 | 17 | -178 | -427 |
Asset Writedown & Restructuring Costs | - | 530 | - | 23 | - |
Loss (Gain) From Sale of Investments | -24 | -14 | 7 | 52 | -12 |
Stock-Based Compensation | - | - | - | - | 22 |
Provision & Write-off of Bad Debts | 89 | -11 | 278 | -131 | 470 |
Other Operating Activities | -5,339 | -1,345 | -843 | -693 | -400 |
Change in Accounts Receivable | 3,860 | -593 | -3,413 | -2,223 | -2,389 |
Change in Inventory | -1,427 | -653 | 424 | 191 | 564 |
Change in Accounts Payable | 1,333 | 403 | -281 | 1,020 | 74 |
Change in Other Net Operating Assets | 2,689 | -1,154 | 176 | 1,639 | -563 |
Operating Cash Flow | 17,683 | 16,968 | 12,116 | 8,491 | 465 |
Operating Cash Flow Growth | 4.21% | 40.05% | 42.69% | 1726.02% | -84.44% |
Capital Expenditures | -3,883 | -4,011 | -3,394 | -1,463 | -2,328 |
Sale of Property, Plant & Equipment | 14 | 950 | 20 | 305 | 538 |
Cash Acquisitions | -77 | - | - | - | -1,031 |
Sale (Purchase) of Intangibles | -28 | -904 | -193 | -593 | -99 |
Investment in Securities | -17,009 | -11,046 | -6,035 | -4,275 | 2,039 |
Other Investing Activities | 170 | 870 | -737 | 1,255 | 824 |
Investing Cash Flow | -20,817 | -14,145 | -10,327 | -4,771 | -53 |
Short-Term Debt Issued | 260 | - | 1,978 | - | 1,382 |
Long-Term Debt Issued | 4,000 | - | - | - | - |
Total Debt Issued | 4,260 | - | 1,978 | - | 1,382 |
Short-Term Debt Repaid | - | -892 | - | -2,390 | - |
Long-Term Debt Repaid | -24 | -34 | -21 | -20 | -24 |
Total Debt Repaid | -24 | -926 | -21 | -2,410 | -24 |
Net Debt Issued (Repaid) | 4,236 | -926 | 1,957 | -2,410 | 1,358 |
Repurchase of Common Stock | - | - | -2,537 | -74 | - |
Common Dividends Paid | -902 | -1,078 | -1,708 | -1,004 | -822 |
Other Financing Activities | -359 | -103 | -181 | -142 | -188 |
Financing Cash Flow | 2,975 | -2,107 | -2,469 | -3,630 | 348 |
Foreign Exchange Rate Adjustments | 948 | -220 | 65 | 118 | 93 |
Net Cash Flow | 789 | 496 | -615 | 208 | 853 |
Free Cash Flow | 13,800 | 12,957 | 8,722 | 7,028 | -1,863 |
Free Cash Flow Growth | 6.51% | 48.55% | 24.10% | - | - |
Free Cash Flow Margin | 31.54% | 29.24% | 21.79% | 25.95% | -9.57% |
Free Cash Flow Per Share | 77.05 | 72.34 | 48.59 | 38.50 | -10.21 |
Cash Interest Paid | - | 176 | 181 | 142 | 170 |
Cash Income Tax Paid | - | 3,726 | 2,863 | 1,775 | 482 |
Levered Free Cash Flow | 10,067 | 8,409 | 4,610 | 1,964 | -1,849 |
Unlevered Free Cash Flow | 10,296 | 8,515 | 4,685 | 2,056 | -1,767 |
Change in Working Capital | 6,455 | -1,997 | -3,094 | 627 | -2,314 |